Verve Therapeutics Inc (VERV)
6.67
-0.07
(-1.08%)
USD |
NASDAQ |
Apr 18, 11:41
Verve Therapeutics Price to Book Value: 0.9303 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 0.9405 |
| April 16, 2024 | 0.9959 |
| April 15, 2024 | 1.020 |
| April 12, 2024 | 1.060 |
| April 11, 2024 | 1.126 |
| April 10, 2024 | 1.117 |
| April 09, 2024 | 1.220 |
| April 08, 2024 | 1.172 |
| April 05, 2024 | 1.188 |
| April 04, 2024 | 1.211 |
| April 03, 2024 | 1.215 |
| April 02, 2024 | 1.160 |
| April 01, 2024 | 1.784 |
| March 28, 2024 | 1.852 |
| March 27, 2024 | 1.840 |
| March 26, 2024 | 1.784 |
| March 25, 2024 | 1.836 |
| March 22, 2024 | 1.809 |
| March 21, 2024 | 1.842 |
| March 20, 2024 | 1.866 |
| March 19, 2024 | 1.815 |
| March 18, 2024 | 1.856 |
| March 15, 2024 | 1.926 |
| March 14, 2024 | 1.897 |
| March 13, 2024 | 2.000 |
| Date | Value |
|---|---|
| March 12, 2024 | 1.942 |
| March 11, 2024 | 2.011 |
| March 08, 2024 | 2.087 |
| March 07, 2024 | 2.084 |
| March 06, 2024 | 2.102 |
| March 05, 2024 | 2.112 |
| March 04, 2024 | 2.209 |
| March 01, 2024 | 2.272 |
| February 29, 2024 | 2.378 |
| February 28, 2024 | 2.505 |
| February 27, 2024 | 2.446 |
| February 26, 2024 | 2.014 |
| February 23, 2024 | 1.876 |
| February 22, 2024 | 1.858 |
| February 21, 2024 | 1.831 |
| February 20, 2024 | 1.822 |
| February 16, 2024 | 1.790 |
| February 15, 2024 | 1.816 |
| February 14, 2024 | 1.743 |
| February 13, 2024 | 1.667 |
| February 12, 2024 | 1.836 |
| February 09, 2024 | 1.695 |
| February 08, 2024 | 1.615 |
| February 07, 2024 | 1.497 |
| February 06, 2024 | 1.567 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9303
Minimum
Apr 18 2024
8.759
Maximum
Sep 10 2021
3.404
Average
2.496
Median
Dec 22 2023
Price to Book Value Benchmarks
| Acorda Therapeutics Inc | -- |
| Eli Lilly and Co | 65.98 |
| Intellia Therapeutics Inc | 1.984 |
| Beam Therapeutics Inc | 2.019 |
| Editas Medicine Inc | 1.310 |
Price to Book Value Related Metrics
| PS Ratio | 38.14 |
| Price | 6.67 |
| Earnings Yield | -46.78% |
| Market Cap | 557.74M |